Zymeworks Competitors and Similar CompaniesClear all
Zymeworks's competitors and similar companies include NovoCure and Foghorn Therapeutics.
 Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | |
Founding Date | Founding Date 2003 | Founding Date 2000 | Founding Date 2016 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Vancouver, CA HQ Seattle, US | Locations Cambridge, US HQ Cambridge, US | |
Employees | Employees 45519% increase | Employees 1,488 | Employees 1123% decrease |
Valuation ($) | Valuation ($) 973.3 m | Valuation ($) 1.8 b | Valuation ($) 452 m |
Financial | |||
Revenue (est.) | Revenue (est.) $106m (FY, 2025) | Revenue (est.) $655.4m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) |
Net income | Net income ($81.1m) (FY, 2025) | Net income ($136.2m) (FY, 2025) | Net income ($74.4m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 125.9m | Total funding raised N/A | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
NovoCure
HQ
Saint Helier, JE
Employees
1,488
NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
View companyFoghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company